484 related articles for article (PubMed ID: 30937839)
1. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation.
Shao BZ; Wang SL; Pan P; Yao J; Wu K; Li ZS; Bai Y; Linghu EQ
Inflammation; 2019 Aug; 42(4):1147-1159. PubMed ID: 30937839
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease.
Perera AP; Kunde D; Eri R
Curr Pharm Des; 2017; 23(16):2321-2327. PubMed ID: 28155620
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 Inflammasome and Inflammatory Bowel Disease.
Zhen Y; Zhang H
Front Immunol; 2019; 10():276. PubMed ID: 30873162
[TBL] [Abstract][Full Text] [Related]
4. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
Lazaridis LD; Pistiki A; Giamarellos-Bourboulis EJ; Georgitsi M; Damoraki G; Polymeros D; Dimitriadis GD; Triantafyllou K
Dig Dis Sci; 2017 Sep; 62(9):2348-2356. PubMed ID: 28523573
[TBL] [Abstract][Full Text] [Related]
5. NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease.
Zhang J; Zeng S; Wang P; Chen Y; Zeng C
Curr Drug Targets; 2023; 24(14):1106-1116. PubMed ID: 37946354
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory bowel diseases and inflammasome].
Kim JM
Korean J Gastroenterol; 2011 Dec; 58(6):300-10. PubMed ID: 22198227
[TBL] [Abstract][Full Text] [Related]
7. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors.
Bauer C; Duewell P; Lehr HA; Endres S; Schnurr M
Dig Dis; 2012; 30 Suppl 1():82-90. PubMed ID: 23075874
[TBL] [Abstract][Full Text] [Related]
8. Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells.
Yue C; Yang X; Li J; Chen X; Zhao X; Chen Y; Wen Y
Biochem Biophys Res Commun; 2017 Aug; 490(2):541-551. PubMed ID: 28629999
[TBL] [Abstract][Full Text] [Related]
9. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
10. Role and mechanism of the nod-like receptor family pyrin domain-containing 3 inflammasome in oral disease.
Lv K; Wang G; Shen C; Zhang X; Yao H
Arch Oral Biol; 2019 Jan; 97():1-11. PubMed ID: 30315987
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
[TBL] [Abstract][Full Text] [Related]
13. NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis.
Ranson N; Veldhuis M; Mitchell B; Fanning S; Cook AL; Kunde D; Eri R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583612
[TBL] [Abstract][Full Text] [Related]
14. Huaier aqueous extract protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NLRP3 inflammasome activation.
Wang L; Yu Z; Wei C; Zhang L; Song H; Chen B; Yang Q
Oncotarget; 2017 May; 8(20):32937-32945. PubMed ID: 28380426
[TBL] [Abstract][Full Text] [Related]
15. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.
Gong Z; Zhao S; Zhou J; Yan J; Wang L; Du X; Li H; Chen Y; Cai W; Wu J
Mol Immunol; 2018 Dec; 104():11-19. PubMed ID: 30396035
[TBL] [Abstract][Full Text] [Related]
16. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
[TBL] [Abstract][Full Text] [Related]
17. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
Zhong Z; Sanchez-Lopez E; Karin M
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
[TBL] [Abstract][Full Text] [Related]
18. NLRP3: A promising therapeutic target for autoimmune diseases.
Shen HH; Yang YX; Meng X; Luo XY; Li XM; Shuai ZW; Ye DQ; Pan HF
Autoimmun Rev; 2018 Jul; 17(7):694-702. PubMed ID: 29729449
[TBL] [Abstract][Full Text] [Related]
19. Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation.
Mai CT; Wu MM; Wang CL; Su ZR; Cheng YY; Zhang XJ
Mol Immunol; 2019 Jan; 105():76-85. PubMed ID: 30496979
[TBL] [Abstract][Full Text] [Related]
20. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]